Programm & Abstracts                 "Innovationen in der Augenheilkunde"

Aktuelle Tagungsinformationen
   News and Updates

Anmeldung zur Tagung
   Registration
Hotelbuchung
   Hotel Registration
Grußwort
   Welcome address
Beteiligte Gesellschaften
   Societies involved
Eröffnung des Kongresses
   Opening Ceremony
Preise
   Awards
Wissenschaftliches Programm
   Scientific program
Posterpräsentationen
   Poster Presentation
Kurse
   Courses
Begleitende Veranstaltungen
   Collateral Events
Rahmenprogramm
   Social program
Jubiläumsparty
   Jubilee Party
DOG Information
   DOG Information
Allgemeine Informationen
   General Information
Autorenindex
   Index of Authors
Ausstellerliste
   Exhibitors
Sponsoren
   Sponsors
Teilnahmegebühren
   Registration fees
Impressum



DOG Homepage

Results of selective Betoptic -S Treatment of Initial Open-angle Glaucoma

Biryeh T.,
Weißrussische Staatliche Medizinische Universität (Minsk)

Materials and methods: The objective of the investigation was to study the influence of Betoptic-S in stabilization of the glaucomatous process with patients newly-diagnosed for primary open-angle glaucoma (POAG). 21 patient with IOG, aged 36-76 yrs (10 males, 11 females) were under our observation. Initial stage was diagnosed in 18 eyes, developed stage - in 20, far-advanced stage - in 4 eyes. Compensational level of intraocular pressure (IOP) was diagnosed with 9 patients, subcompensation - with 10 patients, noncompensated IOP - with 2 patients. On diagnosing glaucoma, the patients were prescribed instillations of Betoptic-S 25% twice a day. The term of the research covered 6 months.
Results and discussion: The Betoptic -S instillation resulted in lowering IOP by an average of 3,6 mm Hg in majority of the patients (Po average was 24,0 ± 0,73 mm Hg before the treatment and 20,4 ± 0,58 mm Hg after the treatment). Though, compensation of IOP (Po>30,0 mm) was not achieved with 3 patients despite additional instillations of pilocarpin 1% 3 time a day. 2 of the patients were recommended surgical treatment, and one-laser therapy. Thus, our investigation has shown that decrease of IOP with patients treated with Betoptic-S was achieved solely due to depression of the aqueous humor secretion by 0,94 mm3/min (34,6% of the initial level) on the average. The peripheral visual field and the central visual field were examined with 12 patients (24 eyes).
Summary: The analysis of the functional status of the visual field verified increase of total average lightsensitivity of the retina and of the total average values in the nasal quadrants of the peripheral visual field of the patients treated with Betoptic-S. The obtained results verify decrease of the total number of defects in the peripheral visual field as well as decrease of the total number of defects and that of their depths and area in the central visual field. The attained effect of stabilization and improvement of the functional status of the visual field (decrease of IOP and, consequently, stabilization of the glaucoma process with most of the patients testifies to doubtless improvement of the ganglious cells status and neurons of the optical nerve and to the neuroprotecting activity of the preparation used.

Zurück/Back